Raymond James raises Fulgent Genetics stock price target to $36 on strong performance
STONY BROOK, N.Y. - Applied DNA Sciences, Inc. (NASDAQ:BNBX), a micro-cap company with a market value of $4.84 million and annual revenue of $3.74 million, announced Tuesday the launch of BNBX.io, a dashboard providing real-time portfolio metrics about the company’s BNB treasury holdings and capitalization structure.
The dashboard aims to offer transparency into the company’s yield-focused BNB treasury strategy, according to Patrick Horsman, Chief Investment Officer at BNBX.
As of Monday, the company reported holding approximately 15,553 BNB through direct holdings and OBNB Trust units, alongside $8.4 million in cash. The company currently has 4.35 million shares outstanding, with 23.71 million shares on a fully diluted basis. According to InvestingPro analysis, while BNBX maintains more cash than debt, the company is quickly burning through its cash reserves, which investors should monitor closely.
The launch follows the company’s recent private placement of up to $58 million to establish its BNB treasury, according to the press release.
BNBX plans to enhance the dashboard with additional information as it implements its yield strategies. The company also intends to launch a weekly newsletter covering BNB updates and company-specific information.
Company representatives will speak at upcoming events including SALT London on November 5, 2025, discussing "New Access Points: DeFi, Tokenization and DATs," and at Digital Commonwealth the same day on "DATs 2.0 An Evolving Market."
The company noted that the dashboard contains non-GAAP financial information and should not replace official SEC filings for complete financial information.
Applied DNA Sciences describes itself as providing institutional-grade access to the Binance ecosystem through non-directional yield strategies and long BNB exposure, while also commercializing nucleic acid production solutions for biopharmaceutical and diagnostics markets.
In other recent news, Applied DNA Sciences Inc. announced the successful closing of a private investment in public equity (PIPE) financing, raising approximately $27 million in gross proceeds. This financing, led by institutional DeFi and TradFi investors, included cash, stablecoins, and units of the OBNB trust. The company may potentially receive up to an additional $31 million from future warrant exercises. Applied DNA has also shifted its focus to a BNB digital asset treasury strategy, reflecting this strategic pivot by changing its ticker symbol from "APDN" to "BNBX." This change, effective October 7, 2025, aligns with the company’s new focus on yield generation and token accumulation within the Binance ecosystem. Additionally, the company plans to maintain its nucleic acid production solutions business while implementing its digital asset management approach. Applied DNA’s business development and technical teams are set to present their nucleic acid solutions at two industry conferences in Boston, showcasing their synthetic DNA platform and IVT Discovery Kit. These recent developments indicate a significant strategic shift for Applied DNA as it explores new financial and operational avenues.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.